About pharma
Greater Access to New Weight Loss Meds Could Save More Than 40,000 Lives Per Year “Making the drugs available to all obese people and overweight type 2 diabetics could save more than 42,000 American lives annually.”
About 45% of the U.S. adult population is eligible to take the weight-loss drugs by those standards.”
Why Does an $84,000 Drug in the U.S. Cost Less Than $1,000 in India An excellent article in Forbes reviews the relevant issues.
About healthcare IT
100M people impacted by massive Change Healthcare cyberattack: OCR “UnitedHealth Group has officially disclosed that 100 million people were affected by the massive cyberattack on Change Healthcare earlier this year.”
About healthcare finance
AbbVie inks $1.4B Aliada buyout, landing ex-J&J Alzheimer's drug to leap the blood-brain barrier “AbbVie has agreed to pay $1.4 billion to buy Aliada Therapeutics. The acquisition will give AbbVie control of an Alzheimer’s disease drug candidate Aliada in-licensed from Johnson & Johnson to try to improve on the first generation of anti-amyloid-beta antibodies.
Aliada is developing an antibody that binds to pyroglutamate amyloid beta, a form of the peptide found in the brains of people with Alzheimer’s.”